INBX

Q: What is the price of Inhibrx (INBX) today?

The price of Inhibrx (INBX) today is $ 76.21, with return of 421.27% compared to the last year. The price of Inhibrx (INBX) started the year trading around $ 15.40 and today it is at $ 76.21. Follow the real-time price chart, the historical price of Inhibrx (INBX) and international markets.

Q: When does Inhibrx (INBX) pay dividends?

Inhibrx (INBX) did not distribute dividends in the last year.

Q: Is Inhibrx (INBX) worth it?

Currently, Inhibrx (INBX) is priced at $ 76.21, with a P/E of -7.70%, representing a deviation of -985% from its historical average P/E. In the last year, the stock showed a variation of 421.27 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 421.27%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Inhibrx (INBX) stock?

Investing in stocks of Inhibrx (INBX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Inhibrx (INBX) yield today?

The yield of Inhibrx (INBX) was -3.69% in the last month, 421.27% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Inhibrx (INBX) today, the total investment would be $ 7,621.00, based on the current price of $ 76.21.If past performance were to repeat, the return on your investment would be:In 1 year: $ 39,725.99In 5 years: $ 7,621.00In 10 years: $ 7,621.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Inhibrx Inc.

Price

$ 76.21

return (12m)

421.27%

p/e

-7.70

p/bv

32.41

DIVIDEND YIELD

0.00%

price INBX

INBX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of INBX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-3.69%

3 months

186.83%

1 year

421.27%

2 years

177.84%

5 years

0.00%

10 years

0.00%

Fundamentals INBX

review the fundamentals of Inhibrx shares

P/E

-7.70

Sector: -3.65 Industry: -3.65

P/SALES RATIO (PSR)

852.54

Sector: -3.79 Industry: -3.79

P/BV

32.41

Sector: 2.05 Industry: 2.05

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-87.39%

Sector: -63.54% Industry: -63.54%

ROE

-421.10%

Sector: -66.83% Industry: -66.83%

ROIC

-571.86%

Sector: -1,129.15% Industry: -1,129.15%

NET MARGIN

-100.00%

Sector: -41.11% Industry: -41.11%

GROSS MARGIN

100.00%

Sector: 39.39% Industry: 39.39%

OPERATING MARGIN

-100.00%

Sector: -40.98% Industry: -40.98%

P/EBITDA

-8.32

Sector: -3.65 Industry: -3.65

P/EBIT

-8.17

Sector: -3.78 Industry: -3.78

P/ASSET

6.73

Sector: 1.49 Industry: 1.49

BVPS

2.46

Sector: 1.75 Industry: 1.75

EPS

-10.34

Sector: -2.04 Industry: -2.04

EQUITY RATIO

0.21

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals INBX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	20.28	0.00	0.00%	2.43%	$ 509.48 B	27.26%
PFE	14.95	1.58	10.56%	6.65%	$ 146.96 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	14.47	8.35	57.70%	3.36%	$ 223.00 B	32.78%
MRK	13.16	0.00	0.00%	3.23%	$ 250.55 B	29.63%
AZN	29.65	6.06	20.45%	1.74%	$ 278.65 B	16.17%
BMY	17.67	5.74	32.47%	4.73%	$ 106.71 B	12.57%
GILD	18.45	6.98	37.80%	2.61%	$ 149.66 B	27.88%
ZTS	19.83	9.74	49.11%	1.69%	$ 52.57 B	28.21%
HALO	12.22	14.44	118.17%	0.00%	$ 7.28 B	47.91%
REGN	16.84	2.49	14.79%	0.47%	$ 77.09 B	32.13%
AMGN	24.40	17.77	72.82%	3.00%	$ 170.94 B	19.47%
VRTX	31.49	6.68	21.22%	0.00%	$ 115.72 B	31.35%
MCK	25.02	-174.59	-697.75%	0.36%	$ 100.91 B	1.04%
CAH	29.57	-17.27	-58.40%	1.03%	$ 47.17 B	0.68%
ADMA	22.57	10.96	48.57%	0.00%	$ 4.73 B	42.87%
BIIB	15.91	1.41	8.83%	0.00%	$ 25.59 B	15.98%
HRMY	12.65	2.81	22.24%	0.00%	$ 2.35 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

INBX Historical Dividends

current DY: 0.00%

5-year average DY: 5.61%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	05/30/2024	06/20/2024	0,85000000

ABOUT THE COMPANY Inhibrx

Inhibrx Inc.

Average user rating I10

4.0 (1 people)

United States

8 years

Founded: 2017

2020

Time since IPO - 5 years

91

Employees

The Company Inhibrx Inc. (United States), is listed on Nasdaq with a market value of $ 1.19 Billion, having an equity of $ 36.83 Millions.

With a total of 91 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 1.40 Million, which generated a loss in the amount of $ -155.09 Millions.

As for its main indicators, the Company has a P/E ratio of -7.70, a P/BV ratio of 32.41 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker INBX.

Market cap

$ 1.19 Billion

Net worth

$ 36.83 Millions

US$ 36,830,000.00

Assets

$ 177.47 Millions

US$ 177,470,000.00

Total Shares Outstanding

15.00 Millions

15,000,000

Average Daily Trading Volume

$ 435.13 Thousand

US$ 435,125.42

Sector

Health Care

Industry

Biotechnology

INBX

INBX revenue and profits

Financial Results INBX

DRAG THE FRAME TO SEE MORE DATA

INBX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 823.01 47,03% (12M)

P/E

25.02

0.36%

ROE

-697.75%

P/BV

-174.59

CAH - Cardinal Health

$ 199.96 74,48% (12M)

P/E

29.57

1.03%

ROE

-58.40%

P/BV

-17.27

JNJ - Johnson & Johnson

$ 214.17 53,44% (12M)

P/E

20.28

2.43%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 100.26 4,80% (12M)

P/E

13.16

3.23%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 26.43 7,24% (12M)

P/E

14.95

6.65%

ROE

10.56%

P/BV

1.58

ABBV - AbbVie

$ 227.45 38,21% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 91.56 41,20% (12M)

P/E

29.65

1.74%

ROE

20.45%

P/BV

6.06

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 823.01 47,03% (12 M)

P/L

25.02

0.36%

ROE

-697.75%

P/VP

-174.59

CAH - Cardinal Health

$ 199.96 74,48% (12 M)

P/L

29.57

1.03%

ROE

-58.40%

P/VP

-17.27

JNJ - Johnson & Johnson

$ 214.17 53,44% (12 M)

P/L

20.28

2.43%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 100.26 4,80% (12 M)

P/L

13.16

3.23%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 26.43 7,24% (12 M)

P/L

14.95

6.65%

ROE

10.56%

P/VP

1.58

ABBV - AbbVie

$ 227.45 38,21% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 91.56 41,20% (12 M)

P/L

29.65

1.74%

ROE

20.45%

P/VP

6.06

Frequently Asked Questions

What is the price of Inhibrx (INBX) today?

The price of Inhibrx (INBX) today is $ 76.21, with return of 421.27% compared to the last year. The price of Inhibrx (INBX) started the year trading around $ 15.40 and today it is at $ 76.21. Follow the real-time price chart, the historical price of Inhibrx (INBX) and international markets.

When does Inhibrx (INBX) pay dividends?

Inhibrx (INBX) did not distribute dividends in the last year.

Is Inhibrx (INBX) worth it?

Currently, Inhibrx (INBX) is priced at $ 76.21, with a P/E of -7.70%, representing a deviation of -985% from its historical average P/E. In the last year, the stock showed a variation of 421.27 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 421.27%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Inhibrx (INBX) stock?

Investing in stocks of Inhibrx (INBX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Inhibrx (INBX) yield today?

The yield of Inhibrx (INBX) was -3.69% in the last month, 421.27% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Inhibrx (INBX) today, the total investment would be $ 7,621.00, based on the current price of $ 76.21.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 39,725.99
In 5 years: $ 7,621.00
In 10 years: $ 7,621.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

INBX

Inhibrx Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of INBX

review the fundamentals of Inhibrx shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 5.61%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY Inhibrx

Inhibrx Inc.

United States

8 years

2020

91

Financial Results INBX

INBX cash flow

asset growth - INBX

INBX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions